Mabrouk AA, Tadros MI, El-Refaie WM. Improving the efficacy of Cyclooxegenase-2 inhibitors in the management of oral cancer: Insights into the implementation of nanotechnology and mucoadhesion. Journal of Drug Delivery Science and Technology. 2021;61:102240.
Gebreel RM, Edris NA, Elmofty HM, Tadros MI, Nabarawi MA, Hassan DH. Development and characterization of PLGA nanoparticle-laden hydrogels for sustained ocular delivery of norfloxacin in the treatment of pseudomonas keratitis: An experimental study. Drug Design, Development and Therapy. 2021;15:399-418.
El-Aziz MA, Ismail S, Tadros M, El-Nabarawi M. Low density alfuzosin hydrochloride floating tablets: in vitro characterization and in vivo gastroretentive MRI tracking in healthy volunteers. Pharmaceutical Sciences Asia. 2021;48(5):432-49.
EL-Ghareb WI, Swidan MM, Ibrahim IT, El-Bary AA, Tadros MI, Sakr TM. 99mTc-Doxorubicin-loaded gallic acid-gold nanoparticles (99mTc-DOX-loaded GA-Au NPs) as a multifunctional theranostic agent. Int J Pharm. 2020;586:119514.
Ammar HO, Tadros MI, Salama NM, Ghoneim AM. Therapeutic strategies for erectile dysfunction with emphasis on recent approaches in nanomedicine. IEEE T Nanobiosci. 2020;19(1):11-24.